Paper35889017
Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors.
Alexandrova LA and 4 others. Microorganisms, 2022. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Analogues of Pyrimidine Nucleosides as Mycobacteria Growth Inhibitors. Papers, record 35889017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35889017
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 19-74-10048 | Russian Science Foundation | PubMed | ||
| 20-04-00094 | Russian Foundation for Basic Research | PubMed |
Source PubMed
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16264436 | Acyclic nucleoside phosphonates: a key class of antiviral drugs. | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/16264436 | PubMed |
| 2 | 14529543 | Phosphonomethoxyalkyl analogs of nucleotides. | Curr Pharm Des | 2003 | https://conductscience.org/library/papers/14529543 | PubMed |
| 3 | 31221810 | The global prevalence of latent tuberculosis: a systematic review and meta-analysis. | Eur Respir J | 2019 | https://conductscience.org/library/papers/31221810 | PubMed |
| 4 | 20637609 | Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20637609 | PubMed |
| 5 | 30397682 | The never-ending story of the fight against tuberculosis: from Koch's bacillus to global control programs. | J Prev Med Hyg | 2018 | https://conductscience.org/library/papers/30397682 | PubMed |
| 6 | 27649942 | New prodrugs against tuberculosis. | Drug Discov Today | 2017 | https://conductscience.org/library/papers/27649942 | PubMed |
| 7 | 17696514 | Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. | J Med Chem | 2007 | https://conductscience.org/library/papers/17696514 | PubMed |
| 8 | 26061192 | 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis. | Chem Biol Drug Des | 2015 | https://conductscience.org/library/papers/26061192 | PubMed |
| 9 | 26483967 | 5-Arylaminouracil Derivatives as Potential Dual-Action Agents. | Acta Naturae | 2015 | https://conductscience.org/library/papers/26483967 | PubMed |
| 10 | 11369858 | Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes. | Protein Sci | 2001 | https://conductscience.org/library/papers/11369858 | PubMed |
| 11 | 26875934 | Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosis. | Bioorg Med Chem | 2016 | https://conductscience.org/library/papers/26875934 | PubMed |
| 12 | 16139296 | Structure of the Mycobacterium tuberculosis flavin dependent thymidylate synthase (MtbThyX) at 2.0A resolution. | J Mol Biol | 2005 | https://conductscience.org/library/papers/16139296 | PubMed |
| 13 | 16201017 | Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. | PLoS Pathog | 2005 | https://conductscience.org/library/papers/16201017 | PubMed |
| 14 | 12657046 | Genes required for mycobacterial growth defined by high density mutagenesis. | Mol Microbiol | 2003 | https://conductscience.org/library/papers/12657046 | PubMed |
| 15 | 32942990 | Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices. | BMC Infect Dis | 2020 | https://conductscience.org/library/papers/32942990 | PubMed |
| 16 | 17073640 | The synthesis and antiviral properties of acyclic nucleoside analogues with a phosphonomethoxy fragment in the side chain. | Curr Med Chem | 2006 | https://conductscience.org/library/papers/17073640 | PubMed |
| 17 | 21737530 | Prodrugs--from serendipity to rational design. | Pharmacol Rev | 2011 | https://conductscience.org/library/papers/21737530 | PubMed |
| 18 | 31932744 | Synthesis of water-soluble prodrugs of 5-modified 2'-deoxyuridines and their antibacterial activity. | J Antibiot (Tokyo) | 2020 | https://conductscience.org/library/papers/31932744 | PubMed |
| 19 | 22283813 | Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase. | Curr Top Med Chem | 2012 | https://conductscience.org/library/papers/22283813 | PubMed |
| 20 | 31324515 | Healthy survival after tuberculosis. | Lancet Infect Dis | 2019 | https://conductscience.org/library/papers/31324515 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42599170 | Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42599170 | PubMed |
| 41868124 | Pyrimidine nucleoside: inspiration for novel antimicrobial agent. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41868124 | PubMed |
| 41373859 | 5-Substituted 4-Thiouridines, 4-Thio-2'-deoxyuridines and Their Oligoglycol Carbonate Prodrugs as Promising Antimicrobial Agents. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373859 | PubMed |
| 39835097 | Evaluation of the diagnostic efficiency of fluorescence in situ hybridization for pulmonary tuberculosis: a systematic review and meta-analysis. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39835097 | PubMed |
| 39410888 | Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/39410888 | PubMed |
| 39258667 | Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies. | J Enzyme Inhib Med Chem | 2024 | https://conductscience.org/library/papers/39258667 | PubMed |
| 38474298 | New Biocides Based on N4-Alkylcytidines: Effects on Microorganisms and Application for the Protection of Cultural Heritage Objects of Painting. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474298 | PubMed |
| 37110480 | Mycobacterium tuberculosis Infection: Control and Treatment. | Microorganisms | 2023 | https://conductscience.org/library/papers/37110480 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DTYMK | 1841 | PubTator's text mining | https://conductscience.org/library/genes/1841 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35889017
GET https://conductscience.org/api/papers/v1/35889017/references?page=2